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Abstract: The cells of innate and adaptive immunity, although activated by different ligands, engage in cross talk to en-
sure a successful immune outcome. Toll-like receptors (TLRs) are key components of the innate immune system and have 
the ability to detect microbial infection and trigger host defence responses. Otherwise, human T lymphocytes are able to 
produce most TLRs. Thus, we analyze the capability of some TLR ligands to modulate the function of highly-purified 
CD4
+ T cells. We found that agents acting via TLRs (poly I:C, a TLR3 ligand; flagellin, a TLR5 ligand; and R848, a 
TLR7/8 ligand) are able to regulate the expression of costimulatory molecules both on purified antigen presenting cells 
and on purified T lymphocytes. Moreover, the activation mediated by TLRs determines a kinetic  expression of B7-family 
members such as through an inhibition of T lymphocytes delayed proliferation. These findings suggest a functional role of 
some invading microorganisms in regulating acquired immunity. 
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INTRODUCTION 
Host defense against invading microbial pathogens is 
elicited by the immune system: innate and acquired immu-
nity. Both components of immunity recognize invading mi-
croorganisms as non-self, which triggers immune responses 
to eliminate them. In acquired immunity B and T lympho-
cytes utilize antigen receptors such as immunoglobulins and 
T cell receptors to recognize the non-self.  
At the end of the 20th century, Toll was shown to be an 
essential receptor for host defense against fungal infection in 
Drosophila, which only has innate immunity [1]. Soon after, 
a mammalian homolog of the Toll receptor (now termed 
Toll-like receptor-4, TLR4) was shown to induce expression 
of genes involved in inflammatory responses [1]. These stud-
ies lead innate immunity to become a very attractive subject 
of research. To date, at least eleven members of the Toll fam-
ily have been identified [2]. This type I transmembrane pro-
teins family is characterized by an extracellular domain with 
leucine-rich repeats and a cytoplasmic domain with homol-
ogy to the type I IL-receptor. Functionally, a critical role of 
TLR4 when recognizing the microbial component (i.e. LPS) 
was initially characterized. TLR4 physically associates with 
another molecule called MD-2, along with CD14. This com-
plex is responsible for LPS recognition and signalling [3].  
In this article, we focus our attention on some of the other 
TLR family members such as the TLR3 which recognizes 
double stranded (ds) RNA and induces both the activation of 
NF-kB through MyD88-dependent and independent path-
ways and the production of type I interferons (IFN-/) [4, 
5]. TLR4, as well as TLR2, are pattern recognition receptors 
and signal molecules in response to bacterial lipoproteins and  
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have been implicated in innate immunity and inflammation  
[6]. TLR5 recognizes bacterial flagellin [7]. TLR7 and TLR8  
are structurally highly conserved proteins, and recognize a  
nucleic acid-like structure of the virus [8].   
Costimulatory molecules are considered as critical in   
eliciting cellular proliferation and cytokine production upon  
stimulation. Our knowledge of the signals mediated through 
B7 family molecules (CD80, CD86, B7-H1 and B7-DC) and 
their corresponding receptors (CD28, CD152, and PD-1) 
have become more complex and it is now clear that they play 
critical roles in immune regulation. CD28 is present on rest-
ing T cells and is therefore likely to be related to initial 
costimulatory activity. CD152 (CTLA-4) is an inducible in-
hibitory receptor homologous to CD28 and its engagement 
triggers phosphatases which dephosphorylate molecules of 
the CD3/TCR activation cascade. Conversely, blockade of 
CD152 by specific mAb increases proliferation of CD4
+ T 
cell blasts and clones [9-13].  CD152 mRNA is detectable 
within one hour after T cell activation and cell surface ex-
pression of the protein, although weak, reaches a peak one to 
three days later [14].  In addition, the engagement of CD152 
inhibits specific target cell lysis mediated by CD8
+ T lym-
phocytes [15], down-regulates proliferation of T cells as well 
as IL-2, IFN-, IL-4, and IL-13 production, and up-regulates 
the production of IL-10 and TGF- [16]. PD-1 is expressed 
by B cells, T lymphocytes (activated but not resting), and 
myeloid cells, in contrast to the more restricted expression of 
CD28 and CD152. PD-1 is also expressed in the thymus pri-
marily on CD4
–CD8
– T cells, during this transition from 
double negative to double positive [17]. B7-H1 binds its re-
ceptor PD-1 along with another ligand, B7-DC. The overall 
expression of B7-H1 and B7-DC transcripts is similarly   
found in various lymphoid and non-lymphoid tissues,   
whereas the expression profiles of their proteins are quite   
distinct [18-22].                                                                       
The immunomodulating activity of bacterial components  
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tive molecules on responding cells. For this reason, we veri-
fied the in vitro capacity of flagellin, poly (I:C) and R848 to 
induce the expression of the costimulatory molecules, such 
as CD80, CD86, B7-H1, B7-DC on DC and CD28, CD152, 
PD-1 on T cells. The further understanding of these path-
ways will create new and exciting possibilities for therapeu-
tic fine-tuning of the immune system. 
MATERIALS AND METHODOLOGY 
Cell Cultures 
Human peripheral blood samples were obtained from 
healthy donors according to institutional guidelines. Periph-
eral Blood Mononuclear Cells (PBMC) were purified by 
Ficoll-Hypaque density gradient centrifugation. Monocytes 
and CD4
+ T lymphocytes were isolated by positive selection 
with magnetic beads coated with mAb to CD14 and CD4 
(MACS, Miltenyi Biotec, Auburn, CA, USA). To induce DC 
differentiation, purified monocytes were cultured for 4 days 
in the presence of 200 ng/ml rhGM-CSF (Shering-Plough 
Research Institute, Kenilworth, NJ) and 10ng/ml rhIL-4 
(Immunotools, Friesoythe, Germany). These cells are termed 
immature DCs. Cells were cultured in RPMI 1640 supple-
mented with 10% heat-inactivated FCS, 5 mM L-glutamine 
and 50 IU/ml penicillin-streptomycin (from here on referred 
to as complete medium).  
Antibodies 
The following mAbs were used for immunophenotypic 
and functional analyses: anti-human B7-DC, anti-human PD-
1  (clone MIH 18, and clone JI16 eBiosciences, San Diego, 
CA, USA); PE-conjugated anti-HLA-DR, anti-CD80, anti-
CD86 and anti-CD152 (BD Pharmingen, San Diego, CA, 
USA). Anti-CD28 mAb was a gift from D. Olive (Marseille, 
France).  
In Vitro Stimulation  
The activating factors used in the final concentrations 
were the following: 10 ng/ml Flagellin from S. thyphimurium 
(InvivoGen, San Diego, CA, USA); 1 μg/ml LPS from Es-
cherichia coli, serotype RE515 (referred to as LPS-RE515, 
Alexis-Italy, Florence, Italy) or 1 μg/ml  Escherichia coli 
LPS (referred to as LPS, Sigma-Aldrich, Milan, Italy); 25 
μg/ml poly (I:C) (Polyinosinic:polycytidylic acid; Sigma-
Aldrich); and 10 μM R-848 (imidazoquinoline resiquimod; 
GLSynthesis, Worcester, MA, USA). All of these TLR 
ligands were previously tested in order to obtain doses that 
repeatedly generate the same maximum response (data not 
shown). While studying the activation of DCs via TLR, sev-
eral samples were treated with 7.5 μg/ml rabbit anti-human 
IFN- antibody (Prodotti Gianni, Milan, Italy) to neutralize 
the IFN-. DCs and T lymphocytes were collected after 24, 
48 and 72 hrs, and cell surface markers were tested by flow 
cytometry.  
Flow Cytometry 
The surface phenotype of monocyte-derived DCs was as-
sessed by flow cytometric analysis (FACSCalibur, Becton 
Dickinson). The secondary reagent was PE-labelled goat 
anti-mouse (GAM) antiserum (Southern Biotechnology As-
sociates, Birmingham, AL, USA). 
Quantification of IFN-. 
The level of IFN- in the supernatant was measured using 
an ELISA kit according to the manufacture’s protocol 
(Alexis-Italia, Milano, Italy). The deviation between tripli-
cates was <10% for any reported value. 
Mixed Leukocyte Reaction 
Two-way MLR was used to test functional activity fol-
lowing the activation via TLR. The cells used in these ex-
periments were extracted from a panel of HLA typed labora-
tory volunteers and were selected to provide two HLA-DR 
mismatches. DCs and T lymphocytes were pre-treated for 
three days, as previously described. After in vitro stimulation 
DCs and T lymphocytes were harvested, washed, and resus-
pended in complete medium. Then 10
5 purified allogeneic T 
cells were harvested, washed, and incubated with 10
4 DCs in 
a 0.2 ml volume in 96-well round-bottom plates with 5% 
CO2 at 37°C. Triplicate cultures were set up and incubated 
for 5 days. The cultures were then pulsed with 0.5 mCi 
3H-
thymidine and harvested 18 h later. 
Neutralizing anti-human-CD80, -CD86, -CD152, -B7-
H1, B7-DC, PD-1 mAb, and irrelevant isotype-matched con-
trol mAb were added into the MLR as indicated.  
Statistical Analyses 
Statistical analyses were performed in Microsoft Excel 
5.0 (Microsoft) using two-tailed Student’s t tests. The p value 
<0.05 was considered statistically significant. 
RESULTS 
Flagellin, LPS, poly (I:C) and R848 are able to regulate 
the expression of co-stimulatory receptors on the membrane 
of T lymphocytes.  
First, we analysed the effect of TLR stimulation on 
freshly isolated CD4
+ T lymphocytes (Fig. 1). Results show 
that the stimulation leads to a decrease of CD28 expression, 
whereas the CD152 and PD-1 expression increases after 72 
hrs of treatment (Fig. 1A). In addition, expression of CD69 
was evaluated as a positive control of activation. 
The kinetic of CD28 molecules expression shows that the 
greatest decrease is reached after 72 hrs of stimulation (Fig. 
1B). Interestingly, the CD152 reaches its maximum expres-
sion on the membrane of T cells after 48 hrs of stimulation, 
whereas the maximum for PD-1 is achieved after 72 hrs (Fig. 
1C). In addition, the expression of these inhibitory molecules 
rapidly decreases after 96 hrs (data not shown). 
Although gene knockout mouse demonstrates that TLR-4 
is the key receptor of LPS [23], in vitro transfection assay 
shows that many commercial preparations of LPS [24-25] 
including the E. coli LPS from Sigma [26] possess both 
TLR-4 and TLR-2 activities. For this reason we utilized 
LPS-RE515, a strong activator of TLR-4, that does not acti-
vate TLR-2 or other TLRs [27]. As can be depicted from Fig. 
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cules on T lymphocytes, whereas LPS-RE515 was slightly 
less effective. Thus, we could presume these effects were a 
result of a specific activation via TLR-2 ligand, excluding a 
role mediated by TLR-4 [28-29].  
Flagellin, LPS, poly (I:C) and R848 can regulate the ex-
pression of co-stimulatory molecules on the DC membrane.  
Fresh monocytes, isolated by positive selection using 
magnetic
 beads coated with anti-CD14 mAb, were cultured 
for 4 days with
 GM-CSF and IL-4 (immature DCs, iDC), and 
further stimulated for up to 3
 days with flagellin, LPS, poly 
(I:C) and R848 (mature DCs, mDC). We analyzed the ex-
pression of CD80, CD86, B7-H1 and B7-DC at the cell sur-
face level of iDC and mDC (Fig. 2A). The experiment shown 
represents the study of five donors. The iDC expressed very 
low amount of B7 family receptors and CD80 was the most 
represented (Fig. 2A).  In addition, our results demonstrate 
that flagellin, LPS, poly (I:C) and R848 selectively up-
regulate the expression of all tested costimulatory molecules 
on mDC, although poly (I:C) seems to have a greater effect 
on the induction of B7 family member expressions (compare 
different rows in Fig. 2A). Expression of HLA-DR was 
evaluated through positive control of activation,  
Figure 2B shows both the kinetic of the CD86 expression 
over a period of 72 hrs and the increasing of the mean fluo-
rescence intensity of differently treated DC stained with anti-
CD80, -B7-H1 and -B7-DC mAb also over a 72 hrs period. 
Effect of IFN- Neutralization on the Expression of Co-
Stimulatory Molecules 
Viral, as well as bacteria, infections induce innate im-
mune responses including the production of type I interfer-
ons, IFN-/. Thus, these agents could induce costimulatory 
molecules up-regulation in response to type I interferon sig-
nalling. Otherwise, up-regulation of costimulatory molecules 
on airway epithelium does not seem to depend on these inte-
ferons [29]. For this reason, we measured IFN- concentra-
tion in the supernatant of activated DC (Fig. 3A). The con-
centration of IFN- was markedly increased in the super-
natant of TLR-stimulated cells up to 448 pg/ml (stimulation 
via poly (I:C), compared with that of unstimulated cells). 
Interestingly, although the pretreatment of cell culture with 
saturing amount of anti-IFN- antibody completely neutral-
ized IFN- in the supernatant, it failed to suppress the TLR-
induced upregulation of B7-H1 and B7-DC on DC (Fig. 3B). 
Fig. (1). Flow cytometric analysis of the expression of CD28-family members on the surface of activated T lymphocytes. 
Human CD4
+ T lymphocytes, purified from peripheral blood cells, were cultured as described in Materials and Methods.  
Panel A. Shows that T cells activation via TLRs is able to up-regulate the expression of CD152 and PD-1 at the membrane cell level. Expres-
sion of CD69 was a positive control for T lymphocytes activation. Numbers indicate the Mean Fluorescence Intensity of each curve. 
Panel B. The expression of CD28 decreases following treatment of T cells with flagellin, poly (I:C) and R848. Data are shown as means ± 
standard deviations (error bars) of five experiments. 
Panel C. Shows the increasing of respectively CD152 and PD-1 expression. It is interesting to note that CD152 reaches the maximum of ex-
pression after 48 hrs, whereas PD-1 after 72 hrs. Data are shown as means ± standard deviations (error bars) of five experiments. 
Experimental conditions are:  no stimulus;  flagellin;  + LPS; * poly (I:C);  R848. 4    The Open Microbiology Journal, 2009, Volume 3  Simone et al. 
The Interaction of CD152 and PD-1 with Their Natural 
Ligands Inhibits T Cell Proliferation 
Because TLRs ligation induced the expression of co-
stimulatory molecules on DC as well as the expression of 
inhibitory receptors on T cells, we next examined the im-
munoregulatory properties of flagellin, LPS, poly (I:C), and 
R848 by determining their effects on two-way MLR. Results 
are shown in Fig. 4A. Only the pre-treatment of DCs and T  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Flow cytometric analysis of costimulatory molecules expression on DC. 
Dendritic cells (DC) were obtained by in vitro differentiation of monocytes. For cellular stimulations, DC were cultured for 24, 48 and 72hrs 
with medium alone or in the presence of different stimuli. 
Panel A. Shows the immunophenotype of DC cultured in complete medium (iDC), first row. The other rows represent the membrane expres-
sion of B7-family members on mature DC (mDC) after 72 hrs of treatment with flagellin, poly (I:C) and R848 respectively. Expression of 
MHC-Class II was a positive control for iDC activation. 
Panel B. Only the kinetic of CD86 expression is shown, whereas the expression of the other costimulatory molecules is displayed at the best 
time point (72 hrs). Data are expressed as increasing of Mean fluorescence intensity. Data are shown as means ± standard deviations (error 
bars) of five experiments. 
Experimental conditions are:  no stimulus;  flagellin;  + LPS; * poly (I:C);  R848. TLR Modulate Expression of Costimulatory Molecules  The Open Microbiology Journal, 2009, Volume 3    5 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Effect of IFN-b neutralization on B7-H1 and B7-DC expression. 
iDC were stimulated with flagellin, LPS, poly (I:C) and R848 for 48 h in the presence or absence of anti-IFN-b antibody (7.5 mg/ml). 
Panel A. IFN-b in the supernatant was quantified by ELISA. Data are shown as means ± standard deviations (error bars) of five experiments. 
*Samples that are significantly different (p < 0.05) from the control culture (DC alone). The pre-treatment of cell culture with saturing amount 
of anti-IFN-b antibody completely neutralized IFN-b in the supernatant.  
Panel B. Representative histograms showing the Mean fluorescence intensity of iDC stimulated flagellin, LPS, poly (I:C) or R848 alone, in 
the presence of anti-IFN-b mAb, or in the presence of the isotype-matched control mAb, stained with the indicted mAb. Of note, pre-treatment 
with saturing amount of anti-IFN-b antibody failed to suppress the TLR-induced upregulation of B7-H1 and B7-DC on iDC. Data are shown 
as means ± standard deviations (error bars) of five experiments. 
 
lymphocytes with the TLR-acting agents evidence a decrease 
of thymidine incorporation. Otherwise, T lymphocytes and 
DCs, not pre-activated via TLRs, added to the double-MLR 
assay were able to normally proliferate (Fig. 4A). Finally, in 
order to evidence the role played by CD152 and PD-1 recep-
tors in inhibiting T cell proliferation, we set up a similar ex-
periment adding a cocktail of mAb specific to CD80, CD86, 
CD152 and B7-H1, B7-DC, PD-1. Results (Fig. 4B) proved 
that the interfering mAb reconstitute the normal ability of T 
cells to proliferate. These results were obtained independ-
ently when the cocktail mAb used were directed to the in-
hibitory receptors (i.e. CD152 or PD-1) or to their ligands 
(i.e. CD80, CD86, B7-H1 or B7-DC). Thus it seems that the 
interaction between inhibitory receptors and ligands is 
blocked by these mAb. Furthermore, the adding to the prolif-
eration test of isolated mAb showed a partial reconstitution 
effect (data not shown). Thus, the inhibitory effect seems to 
be related principally to the induction of the expression of 
these B7-family members on the membrane level in this ex-
perimental model. 
DISCUSSION 
The immunomodulating activity of bacterial components 
may be related to their ability to induce expression of reac-
tive molecules on responding cells. The mechanisms by 
which the antigen receptors recognize foreign antigens have 
been intensively analyzed, and the major mechanisms, such 
as diversity, clonality and memory, have been well character-
ized. However, these receptors are present only in verte-
brates, and therefore we do not fully understand the mecha-
nism for non-self recognition in invertebrate organisms. The 
important role of individual TLRs during innate immunity 
has been established, above all in recognizing specific mi-
crobial components derived from pathogens including bacte-
ria, fungi, protozoa and viruses and in inducing antimicrobial 
immune response and furthermore, activation of innate im-
munity is a critical step to the development of antigen-
specific acquired immunity [30-31]. 
DCs are central to T lymphocyte activation and differen-
tiation into T helper and cytotoxic T lymphocyte effectors. 
The generation of acquired immunity begins with DCs cap-
turing microbial antigens in the peripheral tissues. Subse-
quently, DCs migrate to the draining lymph nodes to present 
the processed peptides to naïve T lymphocytes in the context 
of MHC molecules. Once inside the lymph nodes, DCs mi-
grate to the T cell areas, seek out antigen-specific T cells and 
induce their activation and differentiation into effector cells. 
This migration is mediated by TLR-induced downregulation 
of inflammatory chemokine receptors and upregulation of the 
receptors for lymphoid chemokines [32-34].    
Signals through TLRs generally result in the activation 
and maturation of all DCs, as measured by enhanced expres-
sion of the costimulatory molecules CD80, CD86 and CD40. 
Induction of the costimulatory molecules expression on the 
surface of DCs is a particularly important step in the initia-
tion of acquired immunity. The originally described mem-6    The Open Microbiology Journal, 2009, Volume 3  Simone et al. 
bers of the B7 family, B7-1 and B7-2 (CD80 and CD86), 
both costimulate through CD28. However, T cell activity is 
down-modulated by a second receptor for B7-1 and B7-2, 
CD152 [35]. While B7-1 and B7-2 were once thought to rep-
resent the major source of signal 2 by DCs, the recent dis-
covery of additional B7 family members highlights the mo-
lecular complexity of costimulation. The overall expression 
of B7-H1 and B7-DC transcripts is similarly found in various 
lymphoid and non-lymphoid tissues, whereas the expression 
profiles of their proteins are quite distinct. The expression of 
B7-H1 protein, although virtually absent in normal tissues 
except for macrophage-like cells, could be induced in a vari-
ety of tissues and cell types, such as APCs, B cells, T cells, 
epithelial cells, muscle cells, trophoblast, endothelial cells 
and tumour cells. In contrast, expression of B7-DC was only 
detected on DCs and monocytes. B7-H1 was first identified 
as a T cell costimulatory molecule that augments human T 
cell proliferation and IL-10 secretion in the presence of either 
anti-CD3 or alloantigens  [36-37]. B7-DC was also found to 
have similar functions in vitro [38]. However, the receptor 
PD-1 is believed to be an inhibitory receptor because of its 
phenotypes of lymphoproliferative/autoimmune diseases in 
PD-1-deficient mice [39]. This seemingly contradictory data, 
however, could be best interpreted by expression of addi-
tional costimulatory receptor on T cells other than PD-1.  In 
addition, it is known that the induction of type I interferon 
(i.e. IFN- constitutes a primary signal for upregulation of 
costimulatory molecules induced by LPS and (ds) RNA [40, 
41]. Nevertheless, we show that the neutralization of IFN- 
did not block the upregulation of B7-H1 and B7-DC, sug-
gesting that their expression on DCs may not depend, in 
these experimental conditions, on the induction of IFN-.   
TLR messages have been reported to be present in T 
cells. TLRs have been associated principally with the T 
helper cell response [42]. For all of these reasons, we first 
addressed our attention on the capability of TLR-mediated 
signals to modulate the expression of some B7-famly mem-
bers at the membrane level of DCs and T lymphocytes. Sub-
sequently, we have analyzed the functional role
  of TLR-
mediated signals on DC maturation and T cells activation. 
The induction of the expression of inhibitory receptors, such 
as CD152 and PD-1, may represent a mechanism able to 
regulate the intensity of T cell response. What is of interest is 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). The pre-activation of T lymphocytes and DC via TLRs down-regulates the proliferative ability in a two-MLR system. 
Panel A. Pre-treatment of DC and T cells with agents acting via TLRs is able to significatively inhibit a two-way MLR. A positive control 
was the measure of thymidine incorporation of cells not treated (DC + T cells). The data represent the mean of quadruplicate samples. The 
averages ± standard deviations (error bars) of three different experiments are shown. Similar results were obtained in three separate experi-
ments from a variety of donor/recipient combinations. *, Samples that are significantly different (p < 0.05) from the control culture (DC + T 
cells). 
Panel B. A cocktail of mAb specific for the B7/CD28-family members added to the assay is able to revert the capability of T lymphocytes to 
proliferate. In addition, the presence of a cocktail of irrelevant isotype-matched mAb does not perturbate the inhibitory effect observed.  The 
averages ± standard deviations (error bars) of three different experiments are shown. Similar results were obtained in three separate experi-
ments from a variety of donor/recipient combinations.  
*Samples that are significantly different (p < 0.05) from the control culture (DC + T cells).  
**Samples that are significantly different (p < 0.05) from the control culture (DC + T cells + TLR activation). TLR Modulate Expression of Costimulatory Molecules  The Open Microbiology Journal, 2009, Volume 3    7 
the kinetic of expression of these two molecules and of their 
counter-receptors, showing the possibility to down-regulate 
the on-going of the cellular-mediated immune-response. In 
fact, we observed an inhibition of T cells proliferation in a 
two-way MLR when both CDs and T lymphocytes were pre-
activated via TLRs. In addition, this effect was partially ab-
rogated when mAb specific to B7-family members were 
added to the assay. Thus, we evidenced a possible functional 
role
  of TLRs-stimulation in regulating acquired immunity 
acting both on DCs and T cells level. Finally, the using of 
purified LPS indicates a prevalent role of TLR2 in activating 
T cells (obtained by non-purified LPS), partially excluding 
the effects mediated by TLR4 [28].  
An interesting observation is due to the effects of flagel-
lin in the modulation of costimulatory molecules, both on T 
lymphocytes and DC. These results could suggest that the 
bacterial protein flagellin, the primary structural component 
of flagella, plays a role in mediating gut inflammation asso-
ciated with infection by enteric pathogens and in inflamma-
tory bowel disease. Recent findings revealed that flagellin, 
via ligation of TLR-5, is a major means of activating the in-
nate immune responses defining active intestinal inflamma-
tion [43-44]. In addition, human studies demonstrated that 
flagellin is also a major antigenic target of immune responses 
associated with Crohn’s disease, suggesting that immune 
responses to flagellin are not only associated with Crohn’s 
disease, but can promote the pathogenic response. Thus, we 
can hypothesize that the innate immune response to flagellin 
provides a degree of direct protection against flagellated mi-
crobes promoting inflammation and causing perturbations of 
immune cell homeostasis to lead to development of both pro-
tective adaptive immunity and, under select circumstances, a 
pathogenic disease. The ability to appropriately respond to 
pathogenic assault is critical to survival, and the TLRs are 
the first point of contact that we have with invading organ-
isms.  
The mechanisms regulating the TLR response must be 
controlled tightly, first to respond properly to the pathogenic 
challenge and second, to avoid excessive activation of the 
TLR signaling pathway. Therefore control damaging injury 
to the host system following TLR activation. Thus, a better 
understanding of the mechanisms behind TLR activation will 
hopefully lead to the development of novel therapeutic 
strategies in the treatment of inflammatory diseases and auto-
immunity. 
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